According to the latest report by IMARC Group, titled “Artificial Pancreas Device Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global artificial pancreas device systems (APDS) market reached a value of US$ 1,726 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 13.1% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/artificial-pancreas-device-systems-market/requestsample
An artificial pancreas device system (APDS) refers to a medical device that manages and tracks blood sugar and glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a monitor to pump, an insulin infusion pump and a controller. It is commonly available in control to range system (CTR), threshold suspended device system and control to target system (CTT) variants. APDS is widely used to minimize the risks of extreme fluctuations of glucose levels in the body, which leads to hyperglycemia and hypoglycemia by continuously monitoring and automatically adjusting the amount of insulin.
The global artificial pancreas device system market is primarily being driven by the rising prevalence of diabetes and the increasing demand for insulin self-administration equipment. Various product advancements, such as the introduction of software-based wireless and portable devices that assist in automatically detecting glucose levels, are providing an impetus to the market growth. Other factors, including the rising occurrences of pancreatic cancer and other chronic ailments, along with the increasing fundings by various government bodies to introduce novel and advanced treatment methods are creating a positive outlook for the market.
Artificial Pancreas Device Systems Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global artificial pancreas device systems market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Beta Bionics Inc.
- Bigfoot Biomedical Inc.
- Dexcom Inc.
- Inreda Diabetic B.V.
- Insulet Corporation
- Johnson & Johnson
- Medtronic Inc.
- Roche Holding AG
- Tandem Diabetes Care Inc.
Key Market Segmentation:
The report has segmented the global artificial pancreas device systems market on the basis of device type, treatment type, end-user and region.
Breakup by Device Type:
- Threshold Suspend Device Systems
- Control- to-Range Systems
- Control-to-Target Systems
Breakup by Treatment Type:
- Bi-hormonal
- Insulin Only
- Hybrid
Breakup by End-User:
- Hospital
- Medical Centres
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/artificial-pancreas-device-systems-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800